Impact of genomic profiling testing on treatment outcomes in gastrointestinal neuroendocrine carcinoma

被引：0
|
作者：
Ozato, T. [1 ]
Kono, Y. [2 ]
Yamamoto, H. [3 ]
Hirasawa, A. [3 ]
Ennishi, D. [4 ]
Tomida, S. [4 ]
Toyooka, S. [4 ]
Otsuka, M. [2 ]
机构：
[1] Okayama Univ Hosp, Gastroenterol, Okayama, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Gastroenterol & Hepatol, Okayama, Japan
[3] Okayama Univ Hosp, Clin Genom Med, Okayama, Japan
[4] Okayama Univ Hosp, Ctr Comprehens Genom Med, Okayama, Japan
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.264
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
244P
引用
收藏
页码：S1495 / S1495
页数：1
相关论文
共 50 条
  • [21] Genomic profiling of hepatocellular carcinoma
    Parikh, N
    Saranath, D
    PROCEEDINGS OF THE 7TH BIENNIAL CONGRESS OF THE ASIAN SOCIETY OF HEPATO-BILIARY PANCREATIC SURGERY, ASHBPS 2003, 2003, : 99 - 106
  • [22] Genomic Profiling of Secretory Carcinoma
    Krings, Gregor
    Joseph, Nancy M.
    Bean, Gregory
    Onodera, Courtney
    Talevich, Eric
    Yeh, Iwei
    Jordan, Richard
    Grenert, James
    Hosfield, Elizabeth
    Zaloudek, Charles
    Van Zante, Annemieke
    Shin, Sandra J.
    Chen, Yunn-Yi
    MODERN PATHOLOGY, 2017, 30 : 52A - 52A
  • [23] Comprehensive genomic profiling of relapsed and refractory small cell neuroendocrine carcinoma of the urinary bladder.
    Pal, Sumanta K.
    Hoffman-Censits, Jean H.
    Elvin, Julia Andrea
    Vergilio, Jo-Anne
    Suh, James
    Ramkissoon, Shakti
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [24] Genomic Characterization of Renal Medullary Carcinoma and Treatment Outcomes
    Carlo, Maria I.
    Chaim, Joshua
    Patil, Sujata
    Kemel, Yelena
    Schram, Alison M.
    Woo, Kaitlin
    Coskey, Devyn
    Nanjangud, Gouri J.
    Voss, Martin H.
    Feldman, Darren R.
    Hsieh, James J.
    Hakimi, A. Ari
    Chen, Ying-Bei
    Motzer, Robert J.
    Lee, Chung-Han
    CLINICAL GENITOURINARY CANCER, 2017, 15 (06) : E987 - E994
  • [25] Treatment and outcomes of small cell neuroendocrine carcinoma of the cervix (SCCC).
    Schlappe, Brooke
    Jordan, Emmet
    Zhou, Qin
    Iasonos, Alexia
    Leitao, Mario M.
    Park, Kay J.
    Alektiar, Kaled M.
    Zivanovic, Oliver
    Sabbatini, Paul
    Aghajanian, Carol
    O'Cearbhaill, Roisin Eilish
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [26] The impact of primary tumor site on outcomes of treatment with etoposide and cisplatin in grade 3 gastroenteropancreatic neuroendocrine carcinoma
    Yoon, Sang Eun
    Kim, Jung Hoon
    Lee, Su Jin
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    Park, Young Suk
    Kim, Seung Tae
    JOURNAL OF CANCER, 2019, 10 (14): : 3140 - 3144
  • [27] Therapeutic impact and timing of gastrointestinal malignancy genomic profiling: A single-institution experience
    Koenig, Kristin Lynn
    Burkart, Jarred
    Mikhail, Sameh
    Wu, Christina Sing-Ying
    Noonan, Anne M.
    Goldberg, Richard M.
    Bekaii-Saab, Tanios S.
    Ciombor, Kristen Keon
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [28] The emerging clinical relevance of genomic profiling in neuroendocrine tumours
    Burak, Guney Isa
    Ozge, Sonmezler
    Cem, Mujde
    Gulgun, Buyukdereli
    Zeynep, Dogruca Yapar
    Atil, Bisgin
    BMC CANCER, 2021, 21 (01)
  • [29] Clinical Utility of Genomic Profiling of Pancreatic Neuroendocrine Tumors
    Demeure, Michael J.
    Evers, Lisa
    Lenkiewicz, Elizabeth
    Holley, Tara
    Bubendorf, Lukas
    Ruiz, Christian
    Bussey, Kimberly J.
    Barrett, Michael T.
    PANCREAS, 2011, 40 (02) : 326 - 327
  • [30] Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment
    Bussey, Kimberly J.
    Demeure, Michael J.
    FUTURE ONCOLOGY, 2009, 5 (05) : 641 - 655
12345